Serum S-Adenosylhomocysteine (SAH)
Demethylated byproduct formed following transmethylation reactions from SAM, acting as a potent competitive inhibitor of all methyltransferases.
Standard vs. Optimal Reference Rangesnmol/L
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
10 - 25 nmol/L
General reference distribution across unselected commercial populations.
<18 nmol/L
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Reversibly hydrolyzed to homocysteine and adenosine by SAH hydrolase (AHCY); accumulates when homocysteine levels rise.
Differential Diagnosis
Elevated Levels (SAH High)
- •Elevated homocysteine (blocks SAH hydrolysis)
- •Chronic kidney disease
- •Severe vascular endothelial dysfunction
Low Levels (SAH Low)
- •Optimal transmethylation flux
- •Efficient homocysteine clearance
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for SAH
- Targeted organ system imaging or functional dynamic testing related to methyltransferase inhibitor
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Serum S-Adenosylhomocysteine - The New England Journal of Medicine (2021). PMID: 33990124
- [2]SAH Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35222901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Serum S-Adenosylhomocysteine (SAH) into overall healthspan optimization.